NM_004453.4:c.3G>T

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate

The NM_004453.4(ETFDH):​c.3G>T​(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000684 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

ETFDH
NM_004453.4 start_lost

Scores

6
6
4

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 4.52
Variant links:
Genes affected
ETFDH (HGNC:3483): (electron transfer flavoprotein dehydrogenase) This gene encodes a component of the electron-transfer system in mitochondria and is essential for electron transfer from a number of mitochondrial flavin-containing dehydrogenases to the main respiratory chain. Mutations in this gene are associated with glutaric acidemia. Alternatively spliced transcript variants that encode distinct isoforms have been observed. [provided by RefSeq, Aug 2013]
C4orf46 (HGNC:27320): (chromosome 4 open reading frame 46) This gene encodes a small, conserved protein of unknown function that is expressed in a variety of tissues. There are pseudogenes for this gene on chromosomes 6, 8, 16, and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 2 pathogenic variants. Next in-frame start position is after 62 codons. Genomic position: 158682203. Lost 0.099 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-158672459-G-T is Pathogenic according to our data. Variant chr4-158672459-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 2746368.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ETFDHNM_004453.4 linkc.3G>T p.Met1? start_lost Exon 1 of 13 ENST00000511912.6 NP_004444.2 Q16134-1B4DEQ0
ETFDHNM_001281737.2 linkc.3G>T p.Met1? start_lost Exon 1 of 12 NP_001268666.1 Q16134-3B4DEQ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ETFDHENST00000511912.6 linkc.3G>T p.Met1? start_lost Exon 1 of 13 1 NM_004453.4 ENSP00000426638.1 Q16134-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461874
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Multiple acyl-CoA dehydrogenase deficiency Pathogenic:1
Jul 25, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the ETFDH mRNA. The next in-frame methionine is located at codon 62. Disruption of the initiator codon has been observed in individual(s) with multiple Acyl-CoA dehydrogenase deficiency (PMID: 24357026, 29336361, 35314173). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant disrupts a region of the ETFDH protein in which other variant(s) (p.Pro27Ser) have been determined to be pathogenic (PMID: 3126856, 20023066, 27038534; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.53
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
.;T;.
Eigen
Benign
-0.0063
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.90
.;D;D
M_CAP
Pathogenic
0.99
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Uncertain
0.64
D
PROVEAN
Uncertain
-4.0
D;N;N
REVEL
Uncertain
0.56
Sift
Pathogenic
0.0
.;D;D
Sift4G
Pathogenic
0.0
.;D;.
Polyphen
0.0080
.;B;.
Vest4
0.89, 0.92
MutPred
0.98
Gain of catalytic residue at M1 (P = 0.0442);Gain of catalytic residue at M1 (P = 0.0442);Gain of catalytic residue at M1 (P = 0.0442);
MVP
0.94
ClinPred
0.99
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.93
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr4-159593611; API